We promote progress

Our foundation supports the transfer of innovation from medical research to industry, in particular through young entrepreneurship in Switzerland. The foundation aims to strengthen Basel and Switzerland as a scientific and business location, also for the benefit of future generations. We invest in companies in Switzerland or abroad that are active in the field of life sciences and related fields. We value strong founding teams and high-quality science.

Donations (in cash or in the form of shares) to the foundation are tax-exempt.

Portfolio

The JFG Life Sciences Foundation holds participations in the following companies:

Leadership

Patrick Burgermeister is a professional life science investor with a dual background in
molecular biology (Biozentrum Basel) and business administration (HSG St. Gallen). He has led the foundation since its inception in 2019 and was previously one of the partners at venture capital group BioMedPartners. His career also includes positions in banking (as a senior analyst for pharma/biotech) and in the pharmaceutical industry (as a senior portfolio manager at Novartis).

Patrick has been a successful business developer for early stage biotech companies, entering into collaboration and licensing agreements with public and private companies. He has led business development for several early stage companies including Apeiron Biologics and BioVersys.

Board of Trustees

  • Dr. Jürg F. Geigy (President and founder)
  • Dr. Matthias Staehelin (Vischer AG, lawyers and notaries)
  • Prof. Dr. Primo Schär (Vice rector of research, University Basel)
  • Dr. Peter E. Burckhardt (Startup expert)
  • Dr. Jörg Duschmalé

News

Contact

Are you interested to learn more or have a business plan that you would like to share with us? Then please write to patrick.burgermeister(at)jfgstiftung.ch